KLIXAR

Klixar’s first project was a vaccine trial (phase II in patients in ICU) and since then developed into a solid company with a proven track record of successful clinical trials (many of which were rescue studies) conducted not only in Argentina but also in Brazil, Colombia, Mexico and Perú.

Phone: +5411, 4788-9191

E-mail: hello@klixar.com

Web: http://www.klixar.com

Add：Ciudad de la Paz 1887 1º B C1428CPC – CABA, Argentina